190 related articles for article (PubMed ID: 19067475)
1. Ciprofloxacin strongly inhibits clozapine metabolism: two case reports.
Brouwers EE; Söhne M; Kuipers S; van Gorp EC; Schellens JH; Koks CH; Beijnen JH; Huitema AD
Clin Drug Investig; 2009; 29(1):59-63. PubMed ID: 19067475
[TBL] [Abstract][Full Text] [Related]
2. [A patient on clozapine in the general hospital: the need for discussion between specialists from different disciplines and for close monitoring of the patient's plasma level].
van Zuilekom S; Gijsman HJ
Tijdschr Psychiatr; 2013; 55(12):955-9. PubMed ID: 24366834
[TBL] [Abstract][Full Text] [Related]
3. Clozapine toxicity in smoking cessation and with ciprofloxacin.
Brownlowe K; Sola C
Psychosomatics; 2008; 49(2):176. PubMed ID: 18354073
[No Abstract] [Full Text] [Related]
4. Potential Role of Patients' CYP3A-Status in Clozapine Pharmacokinetics.
Tóth K; Csukly G; Sirok D; Belic A; Kiss Á; Háfra E; Déri M; Menus Á; Bitter I; Monostory K
Int J Neuropsychopharmacol; 2017 Jul; 20(7):529-537. PubMed ID: 28340122
[TBL] [Abstract][Full Text] [Related]
5. Variation in the Response of Clozapine Biotransformation Pathways in Human Hepatic Microsomes to CYP1A2- and CYP3A4-selective Inhibitors.
Murray M; Zhang WV; Edwards RJ
Basic Clin Pharmacol Toxicol; 2018 Apr; 122(4):388-395. PubMed ID: 29155491
[TBL] [Abstract][Full Text] [Related]
6. Omeprazole reduces clozapine plasma concentrations. A case report.
Frick A; Kopitz J; Bergemann N
Pharmacopsychiatry; 2003 May; 36(3):121-3. PubMed ID: 12806570
[TBL] [Abstract][Full Text] [Related]
7. [Clozapine-resistant schizophrenia related to an increased metabolism and benefit of fluvoxamine: four case reports].
Papetti F; Morel-Pingault V; Buisse V; Maziere L; Banayan M; Thauby S; Besnard T; Darcourt G; Pringuey D
Encephale; 2007 Oct; 33(5):811-8. PubMed ID: 18357853
[TBL] [Abstract][Full Text] [Related]
8. [Switching to e-cigarettes affects drug concentration].
Berm EJ; Ruijsbroek R; Loonen AJ; Goethals KR; Wilffert B; van Hasselt F
Ned Tijdschr Geneeskd; 2015; 159():A9090. PubMed ID: 26200424
[TBL] [Abstract][Full Text] [Related]
9. Ciprofloxacin increases serum clozapine and N-desmethylclozapine: a study in patients with schizophrenia.
Raaska K; Neuvonen PJ
Eur J Clin Pharmacol; 2000 Nov; 56(8):585-9. PubMed ID: 11151749
[TBL] [Abstract][Full Text] [Related]
10. Increased clozapine plasma concentrations and side effects induced by smoking cessation in 2 CYP1A2 genotyped patients.
Bondolfi G; Morel F; Crettol S; Rachid F; Baumann P; Eap CB
Ther Drug Monit; 2005 Aug; 27(4):539-43. PubMed ID: 16044115
[TBL] [Abstract][Full Text] [Related]
11. Optimising plasma levels of clozapine during metabolic interactions: a review and case report with adjunct rifampicin treatment.
Gee S; Dixon T; Docherty M; Shergill SS
BMC Psychiatry; 2015 Aug; 15():195. PubMed ID: 26265348
[TBL] [Abstract][Full Text] [Related]
12. CYP-mediated clozapine interactions: how predictable are they?
Chetty M; Murray M
Curr Drug Metab; 2007 May; 8(4):307-13. PubMed ID: 17504220
[TBL] [Abstract][Full Text] [Related]
13. Association of clozapine-related metabolic disturbances with CYP3A4 expression in patients with schizophrenia.
Menus Á; Kiss Á; Tóth K; Sirok D; Déri M; Fekete F; Csukly G; Monostory K
Sci Rep; 2020 Dec; 10(1):21283. PubMed ID: 33277605
[TBL] [Abstract][Full Text] [Related]
14. Lack of CYP3A4 inhibition by grapefruit juice and ketoconazole upon clozapine administration in vivo.
Lane HY; Chiu CC; Kazmi Y; Desai H; Lam YW; Jann MW; Chang WH
Drug Metabol Drug Interact; 2001; 18(3-4):263-78. PubMed ID: 11791889
[TBL] [Abstract][Full Text] [Related]
15. A puzzling case of increased serum clozapine levels in a patient with inflammation and infection.
Espnes KA; Heimdal KO; Spigset O
Ther Drug Monit; 2012 Oct; 34(5):489-92. PubMed ID: 22929408
[TBL] [Abstract][Full Text] [Related]
16. Clozapine toxicity due to a multiple drug interaction: a case report.
Cadeddu G; Deidda A; Stochino ME; Velluti N; Burrai C; Del Zompo M
J Med Case Rep; 2015 Apr; 9():77. PubMed ID: 25890012
[TBL] [Abstract][Full Text] [Related]
17. The involvement of CYP1A2 and CYP3A4 in the metabolism of clozapine.
Eiermann B; Engel G; Johansson I; Zanger UM; Bertilsson L
Br J Clin Pharmacol; 1997 Nov; 44(5):439-46. PubMed ID: 9384460
[TBL] [Abstract][Full Text] [Related]
18. Contributions of five human cytochrome P450 isoforms to the N-demethylation of clozapine in vitro at low and high concentrations.
Olesen OV; Linnet K
J Clin Pharmacol; 2001 Aug; 41(8):823-32. PubMed ID: 11504269
[TBL] [Abstract][Full Text] [Related]
19. Clozapine case series.
Sandson NB; Cozza KL; Armstrong SC; Eckermann G; Fischer BA; Phillips B
Psychosomatics; 2007; 48(2):170-5. PubMed ID: 17329613
[TBL] [Abstract][Full Text] [Related]
20. Nonresponse to clozapine and ultrarapid CYP1A2 activity: clinical data and analysis of CYP1A2 gene.
Eap CB; Bender S; Jaquenoud Sirot E; Cucchia G; Jonzier-Perey M; Baumann P; Allorge D; Broly F
J Clin Psychopharmacol; 2004 Apr; 24(2):214-9. PubMed ID: 15206669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
